https://www.medlior.com/insights/back-to-school-and-back-to-germs/ 2016-12-19T17:11:34+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Back-to-school-and-back-to-germs.jpg https://www.medlior.com/wp-content/uploads/2019/12/Back-to-school-and-back-to-germs.jpg https://www.medlior.com/insights/pokemon-and-public-health/ 2016-12-19T18:09:36+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Pok?mon-and-Public-Health.jpg https://www.medlior.com/wp-content/uploads/2019/12/Pok?mon-and-Public-Health.jpg https://www.medlior.com/insights/real-world-treatment-adherence-among-ms-patients/ 2016-12-19T19:05:49+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Real-World-Treatment-Adherence-Among-MS-Patients.jpg https://www.medlior.com/insights/p4-medicine-predictive-personalized-preventive-and-participatory/ 2017-06-27T19:00:39+00:00 https://www.medlior.com/wp-content/uploads/2019/12/P4-Medicine-predictive-personalized-preventive-and-participatory.jpg https://www.medlior.com/wp-content/uploads/2019/12/P4-Medicine-predictive-personalized-preventive-and-participatory.jpg https://www.medlior.com/insights/wearable-technology/ 2017-07-20T18:57:12+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Wearable-Technology.jpg https://www.medlior.com/insights/take-a-stand-against-a-sedentary-lifestyle/ 2017-07-26T18:55:33+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Take-a-Stand-Against-a-Sedentary-Lifestyle.jpg https://www.medlior.com/insights/hurdles-of-canadian-hta/ 2017-08-31T18:54:06+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Hurdles-of-Canadian-HTA.jpg https://www.medlior.com/insights/supporting-reimbursement-decisions-with-oncology-rwe/ 2017-09-28T18:48:01+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Supporting-Reimbursement-Decisions-with-Oncology-RWE.jpg https://www.medlior.com/insights/5-key-considerations-for-big-data-analytics/ 2018-05-11T11:26:03+00:00 https://www.medlior.com/wp-content/uploads/2019/12/5-key.jpg https://www.medlior.com/insights/ispor-on-big-data/ 2018-05-11T11:27:51+00:00 https://www.medlior.com/wp-content/uploads/2019/12/ISPOR.jpg https://www.medlior.com/insights/environmental-scan-grey-literature-searches/ 2018-05-11T11:30:40+00:00 https://www.medlior.com/wp-content/uploads/2019/12/envt-scan.jpg https://www.medlior.com/insights/a-date-with-prom-patient-reported-outcome-measures/ 2018-05-11T11:31:28+00:00 https://www.medlior.com/wp-content/uploads/2019/12/PROM.jpg https://www.medlior.com/insights/patient-data-in-the-electronic-age/ 2018-05-11T11:36:05+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Pt-data.jpg https://www.medlior.com/insights/integrating-data-across-the-health-care-continuum/ 2018-05-11T11:37:21+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Integrating.jpg https://www.medlior.com/insights/routine-collection-of-proms-in-primary-care/ 2018-05-11T11:42:13+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Routine.jpg https://www.medlior.com/insights/how-proms-data-can-enhance-communication-decision-making-between-providers-patients/ 2018-05-11T11:43:29+00:00 https://www.medlior.com/wp-content/uploads/2019/12/how-PROM.jpg https://www.medlior.com/insights/population-health-surveys/ 2018-05-11T11:50:35+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Population-Health-Surveys.jpg https://www.medlior.com/insights/festive-dehydration/ 2018-05-11T11:54:17+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Festive-Dehydration.jpg https://www.medlior.com/insights/real-world-evidence-research/ 2018-05-11T12:02:26+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Real-World-Evidence-Research.jpg https://www.medlior.com/insights/systematic-reviews/ 2018-05-11T12:03:37+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Systematic-Reviews.jpg https://www.medlior.com/insights/literature-reviews/ 2018-05-11T12:04:04+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Literature-Reviews.jpg https://www.medlior.com/insights/mental-health-awareness/ 2018-05-11T12:05:20+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Mental-Health-Awareness.jpg https://www.medlior.com/insights/digital-technologies-health-care/ 2018-05-11T12:09:26+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Digital-Technologies-Health-Care.jpg https://www.medlior.com/insights/digital-technologies-patients/ 2018-05-11T12:11:53+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Digital-Technologies-Patients.jpg https://www.medlior.com/insights/6-key-things-to-include-in-your-evidence-based-reports/ 2018-05-11T12:12:06+00:00 https://www.medlior.com/wp-content/uploads/2019/12/6-Key-Things-To-Include-In-Your-Evidence-Based-Reports.jpg https://www.medlior.com/insights/how-active-are-our-children-a-wake-up-call-for-canadian-youth/ 2018-05-11T12:15:33+00:00 https://www.medlior.com/wp-content/uploads/2019/12/wake-up-call.jpg https://www.medlior.com/insights/pharmaceutical-information-network-pin-database/ 2018-09-21T19:05:08+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Real-World-Evidence-Research.jpg https://www.medlior.com/insights/rwe-for-academics/ 2018-10-02T14:46:27+00:00 https://www.medlior.com/wp-content/uploads/2019/12/rwe-for-academics.jpg https://www.medlior.com/insights/rwe-for-patients/ 2018-10-04T20:14:38+00:00 https://www.medlior.com/wp-content/uploads/2019/12/rwe-for-patients.jpg https://www.medlior.com/insights/rwe-for-providers/ 2018-10-04T20:25:50+00:00 https://www.medlior.com/wp-content/uploads/2019/12/rw-for-providers.jpg https://www.medlior.com/insights/canadian-prescription-drug-insurance-coverage-for-research-purposes/ 2018-10-22T15:40:09+00:00 https://www.medlior.com/wp-content/uploads/2019/12/canadian-prescription-drugs-insurance-coverage.jpg https://www.medlior.com/insights/medlior-insights-from-2018-in-the-world-of-health-outcomes-research/ 2018-12-19T08:19:46+00:00 https://www.medlior.com/wp-content/uploads/2019/12/medliors-top-insights-2018.jpg https://www.medlior.com/insights/medlior-predictions-for-2019-in-the-world-of-health-outcomes-research/ 2019-01-11T10:53:56+00:00 https://www.medlior.com/wp-content/uploads/2019/12/medlior-prediction-2019.jpg https://www.medlior.com/insights/identifying-the-prevalence-and-characteristics-of-patients-with-migraines/ 2019-01-17T07:41:13+00:00 https://www.medlior.com/wp-content/uploads/2019/12/patients-with-migraine-headeaches.jpg https://www.medlior.com/insights/bell-lets-talk_day/ 2019-01-30T01:11:42+00:00 https://www.medlior.com/wp-content/uploads/2019/12/mental-health.jpg https://www.medlior.com/insights/canadian-provincial-administrative-health-data-for-research-its-better-in-alberta/ 2019-02-13T23:08:06+00:00 https://www.medlior.com/wp-content/uploads/2019/12/appointment-appointment-book-blur-40568.jpg https://www.medlior.com/insights/car-t-therapy-challenges-for-implementation-in-canada/ 2019-03-01T20:43:32+00:00 https://www.medlior.com/wp-content/uploads/2019/12/biology-clinic-doctor.jpg https://www.medlior.com/insights/insights-from-the-women-in-data-science-event/ 2019-03-11T15:38:37+00:00 https://www.medlior.com/wp-content/uploads/2019/12/insights-from-women.jpg https://www.medlior.com/insights/gene-therapy/ 2019-03-20T19:00:13+00:00 https://www.medlior.com/wp-content/uploads/2019/12/analyzing-gene-therapy.jpg https://www.medlior.com/insights/real-world-evidence-in-health-technology-assessments/ 2019-03-26T15:46:11+00:00 https://www.medlior.com/wp-content/uploads/2019/12/assessing-health-technology.jpg https://www.medlior.com/insights/cadth-2019-identifying-outcomes-in-real-world-multiple-myeloma/ 2019-04-23T16:43:49+00:00 https://www.medlior.com/wp-content/uploads/2019/12/blood-multiple-myeloma-in-alberta.jpg https://www.medlior.com/insights/medlior-awarded-inaugural-funding-through-government-of-canadas-women-entrepreneurship-fund/ 2019-05-15T14:49:25+00:00 https://www.medlior.com/wp-content/uploads/2019/12/tara-whitney-medlior.jpg https://www.medlior.com/wp-content/uploads/2019/12/WD-stacked-identifier-01.png https://www.medlior.com/insights/the-role-of-modeling-in-rwe/ 2019-05-23T20:35:28+00:00 https://www.medlior.com/wp-content/uploads/2019/12/data-health-economics.jpg https://www.medlior.com/insights/low-density-lipoprotein-cholesterol-management-in-patients-with-atherosclerotic-cardiovascular-diseases-and-pre-existing-diabetes/ 2019-06-11T20:35:09+00:00 https://www.medlior.com/wp-content/uploads/2019/12/blood-sugar-chronic-diabetes.jpg https://www.medlior.com/insights/eha-2019-identifying-outcomes-in-real-world-multiple-myeloma/ 2019-06-19T17:24:03+00:00 https://www.medlior.com/wp-content/uploads/2019/12/blood-multiple-myeloma-in-alberta.jpg https://www.medlior.com/insights/asco-2019-identifying-outcomes-in-real-world-multiple-myeloma/ 2019-06-27T18:56:01+00:00 https://www.medlior.com/wp-content/uploads/2019/12/2019-asco-annual-meeting-hashtag-asco19.png https://www.medlior.com/insights/gene-therapy-and-the-treatment-of-haemophilia/ 2019-07-23T21:51:21+00:00 https://www.medlior.com/wp-content/uploads/2019/12/haemophilia.jpg https://www.medlior.com/insights/htai-2019-best-practices-for-leveraging-artificial-intelligence-in-the-systematic-review-process/ 2019-08-13T19:30:11+00:00 https://www.medlior.com/wp-content/uploads/2019/12/cologne-germany-htai-2019-annual-meeting.jpg https://www.medlior.com/insights/medlior-continuing-our-growth-for-the-future/ 2019-08-13T19:37:05+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Tara-Medlior.jpg https://www.medlior.com/insights/analysis-of-first-line-treatment-non-small-cell-lung-cancer/ 2019-09-12T21:02:51+00:00 https://www.medlior.com/wp-content/uploads/2019/12/robina-weermeijer-Pw9aFhc92P8-unsplash.jpg https://www.medlior.com/insights/applications-of-natural-language-processing-and-machine-learning/ 2019-09-30T20:36:53+00:00 https://www.medlior.com/wp-content/uploads/2019/12/machine-learning-in-big-data.jpg https://www.medlior.com/insights/insights-into-how-real-world-radar-can-improve-research/ 2019-10-08T17:06:12+00:00 https://www.medlior.com/wp-content/uploads/2019/12/support-business-or-research-project.jpg https://www.medlior.com/insights/estimating-the-burden-of-illness-of-obesity-in-alberta/ 2019-10-22T20:56:05+00:00 https://www.medlior.com/wp-content/uploads/2019/12/obesity-burden-illness-in-alberta.jpg https://www.medlior.com/wp-content/uploads/2019/12/ATP_Evolution-scaled.png https://www.medlior.com/insights/real-world-data-can-impact-economic-analyses-of-huntingtons-disease/ 2019-11-05T22:52:48+00:00 https://www.medlior.com/wp-content/uploads/2019/12/dementia-types-huntingtons-disease-inlineimage.jpg https://www.medlior.com/insights/rwd-in-alberta-for-cancer-survivors/ 2019-12-13T17:41:06+00:00 https://www.medlior.com/wp-content/uploads/2020/04/writing-notes-real-world-radar-data.jpg https://www.medlior.com/insights/looking-back-on-2019/ 2019-12-17T18:42:00+00:00 https://www.medlior.com/wp-content/uploads/2020/04/medlior-team-2019-bw.jpg https://www.medlior.com/insights/industry-predictions-for-2020/ 2020-01-09T18:10:30+00:00 https://www.medlior.com/wp-content/uploads/2020/04/Industry-Prediction-Medlilor-2020.jpg https://www.medlior.com/insights/coronavirus-background-and-key-questions/ 2020-03-16T20:31:12+00:00 https://www.medlior.com/wp-content/uploads/2020/04/medlior-meeting-notes-questions.jpg https://www.medlior.com/insights/canadian-real-world-evidence-on-epidemiology-outcomes-and-economics-of-moderate-to-severe-osteoarthritis/ 2020-04-15T21:42:56+00:00 https://www.medlior.com/wp-content/uploads/2020/04/medlior-sorting-through-data.jpg https://www.medlior.com/insights/lipid-lowering-therapy-patterns-and-low-density-lipoprotein-cholesterol-management-among-patients-with-acute-myocardial-infarction-in-alberta-canada/ 2020-04-30T21:40:11+00:00 https://www.medlior.com/wp-content/uploads/2020/04/M-39-B-1-scaled.jpg https://www.medlior.com/insights/case-study-multiple-myeloma/ 2020-05-07T15:39:20+00:00 https://www.medlior.com/wp-content/uploads/2020/04/M-65-B-scaled.jpg https://www.medlior.com/insights/dlbcl-environmental-scan/ 2020-05-13T17:20:26+00:00 https://www.medlior.com/wp-content/uploads/2020/05/M-27-B-scaled.jpg https://www.medlior.com/press_releases/medlior-partners-with-calgary-universities-for-proof-of-concept-study/ 2020-05-13T20:08:07+00:00 https://www.medlior.com/wp-content/uploads/2020/01/M-02-B-scaled.jpg https://www.medlior.com/press_releases/medlior-awarded-inaugural-womens-entrepreneurship-fund-from-government-of-canada/ 2020-05-13T20:11:42+00:00 https://www.medlior.com/wp-content/uploads/2020/04/medlior-team-2019-bw.jpg https://www.medlior.com/press_releases/cholesterol-lowering-drugs-are-under-prescribed-for-prevention-of-atherosclerotic-cardiovascular-disease/ 2020-05-13T20:13:45+00:00 https://www.medlior.com/wp-content/uploads/2019/12/robina-weermeijer-Pw9aFhc92P8-unsplash.jpg https://www.medlior.com/wp-content/uploads/2020/02/statins-graph.jpg https://www.medlior.com/press_releases/canadian-firm-medlior-impacts-global-health-research-with-launch-of-real-world-radar-directory/ 2020-05-13T21:53:26+00:00 https://www.medlior.com/wp-content/uploads/2019/12/medlior-studies-investigation-real-world-radar.jpg https://www.medlior.com/wp-content/uploads/2022/03/medlior-logo-registered.svg https://www.medlior.com/insights/haemophilia-a-slr-project/ 2020-05-28T18:05:03+00:00 https://www.medlior.com/wp-content/uploads/2020/05/M-08-B-scaled.jpg https://www.medlior.com/insights/network-meta-analysis-of-first-line-treatments-for-non-small-cell-lung-cancer/ 2020-06-11T20:38:46+00:00 https://www.medlior.com/wp-content/uploads/2020/04/writing-notes-real-world-radar-data.jpg https://www.medlior.com/insights/case-study-asvcd/ 2020-06-22T20:20:36+00:00 https://www.medlior.com/wp-content/uploads/2020/06/M-28-B-scaled.jpg https://www.medlior.com/insights/hreba-chc/ 2020-07-14T16:03:43+00:00 https://www.medlior.com/wp-content/uploads/2020/07/M-44-B-scaled.jpg https://www.medlior.com/insights/real-world-data-and-inflammatory-bowel-disease/ 2020-07-29T18:22:59+00:00 https://www.medlior.com/wp-content/uploads/2019/12/irritable-bowel-disease.jpg https://www.medlior.com/insights/medlior-publications/ 2021-08-15T19:51:06+00:00 https://www.medlior.com/wp-content/uploads/2020/01/M-02-B-scaled.jpg https://www.medlior.com/insights/challenges-in-drug-development-for-rare-diseases/ 2023-02-28T21:19:44+00:00 https://www.medlior.com/wp-content/uploads/2023/02/slide-12_rare-disease_resized-1.jpg https://www.medlior.com/insights/treatment-intensification-and-ldl-c-thresholds/ 2023-04-05T12:23:33+00:00 https://www.medlior.com/wp-content/uploads/2023/04/Amgen-blog-photo1200.jpg https://www.medlior.com/insights/ispor-boston-2023/ 2023-05-17T14:28:44+00:00 https://www.medlior.com/wp-content/uploads/2023/05/ISPOR-Boston-May-2023_sm2.jpg https://www.medlior.com/insights/cadth-symposium-2023/ 2023-05-25T22:28:41+00:00 https://www.medlior.com/wp-content/uploads/2023/05/CADTH-image_may-2023_sm.jpg https://www.medlior.com/insights/overadjustment-bias/ 2023-06-20T22:55:28+00:00 https://www.medlior.com/wp-content/uploads/2023/06/M-62-B_paul-part-1.jpg http://www.medlior.com/wp-content/uploads/2023/06/overadjustment-bias-diagram.jpg https://www.medlior.com/insights/methods-matter-misinterpreting-covariate-coefficients/ 2023-07-06T00:59:37+00:00 https://www.medlior.com/wp-content/uploads/2023/07/M-63-B_paul-part-2.jpg https://www.medlior.com/wp-content/uploads/2023/07/interpreting-covariates-diagram-1.jpg https://www.medlior.com/wp-content/uploads/2023/07/interpreting-covariates-diagram-2.jpg https://www.medlior.com/insights/cardiology-trends-covid19/ 2023-08-16T22:35:15+00:00 https://www.medlior.com/wp-content/uploads/2023/08/stethoscope_sm.jpg https://www.medlior.com/insights/oncology-early-access-pathways/ 2023-08-23T14:11:21+00:00 https://www.medlior.com/wp-content/uploads/2023/08/oncology-photo.jpg https://www.medlior.com/press_releases/morse-medlior/ 2023-09-14T13:17:15+00:00 https://www.medlior.com/wp-content/uploads/2023/09/MORSE_Medlior-Collaboration-Promo-1200x628-FINAL_2_sm.jpg https://www.medlior.com/strategic_advisors/isporeu-2023/ 2023-11-22T13:46:07+00:00 https://www.medlior.com/wp-content/uploads/2023/11/ISPOR-EU-2023-in-Copenhagen_photo.jpg https://www.medlior.com/press_releases/medlior-nested-knowledge/ 2024-03-14T12:39:49+00:00 https://www.medlior.com/wp-content/uploads/2024/03/Untitled-design-5.jpg https://www.medlior.com/insights/ispor-2024-in-atlanta/ 2024-05-13T18:26:22+00:00 https://www.medlior.com/wp-content/uploads/2024/05/ISPOR-logo-_resized.jpg https://www.medlior.com/insights/the-tragically-hip-man-machine-poem-tour-raising-funding-and-awareness-for-brain-cancer/ 2025-03-03T16:12:05+00:00 https://www.medlior.com/wp-content/uploads/2019/12/The-Tragically-Hip-Man-Machine-Poem-tour-?-raising-funding-and-awareness-for-brain-cancer.jpg https://www.medlior.com/medlior-publications/autoimmune/ms-patient-characteristics-and-healthcare-resource-utilization-from-administrative-databases-real-world-evidence-from-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/canadian-agency-for-drugs-and-technologies-in-health-cadth-emerging-health-technology-for-covid-19-virus-neutralizing-monoclonal-antibodies-against-sars-cov-2/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/bone/trends-in-osteoporotic-fracture-and-related-in-hospital-complications-during-the-covid-19-pandemic-in-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/an-overview-of-liquid-biopsy-for-screening-and-early-detection-of-cancer/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/fluoroquinolones-for-the-treatment-of-other-respiratory-tract-infections-a-review-of-clinical-effectiveness-cost-effectiveness-and-guidelines/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/macrocyclic-and-linear-gadolinium-based-contrast-agents-for-adults-undergoing-magnetic-resonance-imaging/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/gene-therapy-international-regulatory-and-health-technology-assessment-hta-activities-and-reimbursement-status/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/point-of-care-testing-ottawa-canadian-agency-for-drugs-and-technologies-in-health/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/topical-antibiotics-for-infected-wounds-a-review-of-the-clinical-effectiveness-and-guidelines/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/opioid-formulations-with-tamper-resistance-or-abuse-deterrent-features-products-and-policies/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/linking-administrative-data-sets-from-alberta-canada-to-examine-the-impact-of-treatment-adherence-on-health-care-resource-utilization-among-multiple-sclerosis-patients/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/the-impact-of-treatment-adherence-on-clinical-and-economic-outcomes-in-multiple-sclerosis-real-world-evidence-from-alberta-canada-2/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/the-impact-of-treatment-adherence-on-clinical-and-economic-outcomes-in-multiple-sclerosis-real-world-evidence-from-alberta-canada-abstract/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/cad-reviews/environmental-scan-on-pharmaceuticals-requiring-companion-diagnostics-international-journal-of-technology-assessment-in-health-care/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/bone/trends-in-osteoporosis-care-patterns-during-the-covid-19-pandemic-in-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/the-impact-of-treatment-adherence-on-clinical-and-economic-outcomes-in-multiple-sclerosis-real-world-evidence-from-alberta-canada-abstract/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/linking-administrative-data-sets-from-alberta-canada-to-examine-the-impact-of-treatment-adherence-on-health-care-resource-utilization-among-multiple-sclerosis-patients/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/autoimmune/ms-patient-characteristics-and-healthcare-resource-utilization-from-administrative-databases-real-world-evidence-from-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/bone/trends-in-osteoporosis-care-patterns-during-the-covid-19-pandemic-in-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/bone/trends-in-osteoporotic-fracture-and-related-in-hospital-complications-during-the-covid-19-pandemic-in-alberta-canada/ 2025-04-23T14:05:18+00:00 https://www.medlior.com/medlior-publications/health-policy/collaborative-demonstration-project-in-the-province-of-quebec-for-the-operationalization-of-value-based-agreement-moving-from-a-vision-to-implementation/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/medlior-publications/health-policy/early-access-for-innovative-oncology-medicines-a-different-story-in-each-nation/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/medlior-publications/cad-reviews/virtual-care-rapid-scoping-main-report-ottawa-canadian-agency-for-drugs-and-technologies-in-health-cadth/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/medlior-publications/cad-reviews/virtual-care-use-in-primary-care-or-specialty-care-settings-ottawa-canadian-agency-for-drugs-and-technologies-in-health-cadth/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/medlior-publications/cad-reviews/low-dose-ipilimumab-in-combination-with-nivolumab-or-pembrolizumab-for-the-treatment-of-advanced-melanoma/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/medlior-publications/cad-reviews/the-small-house-model-to-support-older-adults-in-long-term-care/ 2025-04-23T14:05:19+00:00 https://www.medlior.com/insights/tara-cowling-on-the-pharma-podcast-data-unleashed-unmasking-the-real-world-evidence-revolution/ 2025-05-16T12:22:07+00:00 https://www.medlior.com/wp-content/uploads/2025/05/Tara-Cowling-on-The-Pharma-Podcast.jpeg https://www.medlior.com/insights/real-world-radar-the-first-online-directory-for-real-world-data-via-becarispublishing-com/ 2025-05-22T16:59:36+00:00 https://www.medlior.com/wp-content/uploads/2025/05/Tara-Cowling-Medlior.png https://www.medlior.com/insights/realizing-fit-for-purpose-real-world-data-via-becarispublishing-com/ 2025-05-22T17:01:07+00:00 https://www.medlior.com/wp-content/uploads/2025/05/Suzanne-McMullen-Medlior_Jan24_v2.png https://www.medlior.com/insights/from-theory-to-practice-implementing-targeted-learning-and-causal-inference-using-real-world-data-via-becarispublishing-com/ 2025-05-22T17:02:38+00:00 https://www.medlior.com/wp-content/uploads/2025/05/Medlior-ISPOR-2024-Targeted-Learning-Deep-Dive-Main-Image-700-x-300-px.png https://www.medlior.com/insights/peering-into-the-crystal-ball-experts-predict-the-future-of-rwe-hta-and-value-based-healthcare-via-becarispublishing-com/ 2025-05-22T17:03:21+00:00 https://www.medlior.com/wp-content/uploads/2025/05/expertpredictions.png https://www.medlior.com/insights/unlocking-the-potential-of-big-data-transforming-healthcare-in-canada-and-the-uk-through-innovation-via-becarispublishing-com/ 2025-05-22T17:04:08+00:00 https://www.medlior.com/wp-content/uploads/2025/05/canada_uk_potentional.jpg https://www.medlior.com/insights/unlocking-the-potential-of-canadian-health-data-transforming-insights-into-action-with-rwe-via-becarispublishing-com/ 2025-05-22T17:05:20+00:00 https://www.medlior.com/wp-content/uploads/2025/05/tara_cowling_eileen_shaw_medlior_gc.png https://www.medlior.com/insights/canadas-rare-disease-strategy-what-is-it-and-why-do-we-care/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2022/04/Infant-scaled.jpeg https://www.medlior.com/insights/indigenous-healthcare/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2022/06/iStock-1337046849-scaled.jpg https://www.medlior.com/insights/alzheimers-disease/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Real-World-Treatment-Adherence-Among-MS-Patients.jpg http://www.medlior.com/wp-content/uploads/2022/06/Image_medlior.jpg https://www.medlior.com/insights/trends-in-osteoporotic-incidences-and-care/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Integrating.jpg https://www.medlior.com/wp-content/uploads/2022/09/Low-Energy-Fractures.png http://www.medlior.com/wp-content/uploads/2022/09/patients-with-osteoporosis-related-healthcare-encounters.png http://www.medlior.com/wp-content/uploads/2022/09/osteoporosis-related-treatments.png https://www.medlior.com/insights/cadth-rwe-framework/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2022/10/the-climate-reality-project-Hb6uWq0i4MI-unsplash-scaled.jpg https://www.medlior.com/insights/mens-mental-health-a-silent-crisis/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2022/11/nik-shuliahin-BuNWp1bL0nc-unsplash-scaled.jpg https://www.medlior.com/insights/2022-a-year-in-review/ 2025-06-28T05:38:37+00:00 https://www.medlior.com/wp-content/uploads/2022/12/Untitled-design-7.png https://www.medlior.com/insights/treatment-of-sars-cov-2/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/02/1643947495-huge-scaled.jpg https://www.medlior.com/insights/the-canadian-survey-on-disability/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2019/12/support-business-or-research-project.jpg https://www.medlior.com/insights/cancer-screening/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2019/12/patients-with-migraine-headeaches.jpg https://www.medlior.com/insights/covid-19-and-opioid-overdose-deaths-insights-from-albertas-substance-use-surveillance-data/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/04/campaign-creators-pypeCEaJeZY-unsplash-scaled.jpg https://www.medlior.com/insights/synthetic-data-and-real-world-evidence-studies/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/04/Unknown.jpeg https://www.medlior.com/wp-content/uploads/2021/04/Screen-Shot-2021-04-29-at-1.46.31-PM.png https://www.medlior.com/wp-content/uploads/2021/04/Screen-Shot-2021-04-29-at-1.47.16-PM.png https://www.medlior.com/insights/epidemiology-treatment-landscape-and-healthcare-resource-utilization-for-patients-with-migraine-in-canada-a-literature-review/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/05/Screen-Shot-2021-05-18-at-5.03.51-PM-e1621379111106.png https://www.medlior.com/insights/ispor-2021/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/06/ISPOR_pic-e1623105986323.png https://www.medlior.com/insights/covid-vaccines-canada/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/08/daniel-schludi-mAGZNECMcUg-unsplash-scaled.jpg http://www.medlior.com/wp-content/uploads/2021/08/Screen-Shot-2021-08-30-at-12.42.40-PM.png http://www.medlior.com/wp-content/uploads/2021/08/Screen-Shot-2021-08-30-at-12.51.40-PM.png http://www.medlior.com/wp-content/uploads/2021/08/Screen-Shot-2021-08-30-at-12.53.37-PM.png http://www.medlior.com/wp-content/uploads/2021/08/Screen-Shot-2021-08-30-at-12.54.44-PM.png https://www.medlior.com/insights/virtual-ispor-2021-burden-of-disease-and-current-treatment-patterns-for-migraine-in-canada/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/09/anh-nguyen-v-NBXj3Yv5o-unsplash.jpg https://www.medlior.com/wp-content/uploads/2021/09/graph1.png https://www.medlior.com/wp-content/uploads/2021/09/Picture2.png https://www.medlior.com/wp-content/uploads/2021/09/Picture1.png https://www.medlior.com/insights/virtual-canadian-congress-of-cardiology-presentation-covid-19-pandemic-induced-disruptions-in-troponin-and-low-density-lipoprotein-cholesterol-laboratory-test-volumes-across-alberta/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/10/testalize-me-0jE8ynV4mis-unsplash-2.jpg https://www.medlior.com/wp-content/uploads/2021/10/Medilor1-scaled.jpg https://www.medlior.com/wp-content/uploads/2021/10/Medlior2.png https://www.medlior.com/wp-content/uploads/2021/10/Medlior3.png https://www.medlior.com/insights/disease-burden-of-huntingtons-disease-in-a-canadian-setting-using-administrative-health-data/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/11/fakurian-design-58Z17lnVS4U-unsplash-2.jpg https://www.medlior.com/insights/cardiac-events-during-the-covid-19/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/11/luis-melendez-Pd4lRfKo16U-unsplash.jpg http://www.medlior.com/wp-content/uploads/2021/11/Medliorblogpost1.png http://www.medlior.com/wp-content/uploads/2021/11/MedliorBlog2.png http://www.medlior.com/wp-content/uploads/2021/11/Medliorblog3.png https://www.medlior.com/insights/looking-back-on-2021/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2021/12/Untitled-design-13-copy.png https://www.medlior.com/insights/looking-forward-to-2022/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2020/04/medlior-sorting-through-data.jpg https://www.medlior.com/insights/value-based-health-care/ 2025-06-28T05:38:38+00:00 https://www.medlior.com/wp-content/uploads/2019/12/assessing-health-technology.jpg https://www.medlior.com/insights/ehden-hdrn-canada-streamlining-access-to-covid-19-data/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2020/08/M-19-B-scaled.jpg https://www.medlior.com/insights/ebmt-2020-work-and-productivity-loss-in-patients-with-acute-leukemia/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2020/04/Industry-Prediction-Medlilor-2020.jpg https://www.medlior.com/insights/network-meta-analysis-of-first-line-therapy-for-advanced-epidermal-growth-factor-receptor-mutation-positive-non-small-cell-lung-cancer-updated-overall-survival-on-the-first-line-treatments-for-advanc/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2020/04/M-65-B-scaled.jpg https://www.medlior.com/insights/indirect-analysis-of-first-line-therapy-for-advanced-non-small-cell-lung-cancer-with-activating-mutations-in-the-japanese-population/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2019/12/appointment-appointment-book-blur-40568.jpg https://www.medlior.com/press_releases/calgary-business-owner-tara-cowling-named-top-100-female-entrepreneurs-in-canada/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2020/01/tara-cowling-headshot-bw.jpg https://www.medlior.com/insights/looking-back-on-2020-a-year-no-one-predicted/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2020/12/Holidays_Pandemic.jpg https://www.medlior.com/insights/looking-forward-for-2021/ 2025-06-28T05:38:39+00:00 https://www.medlior.com/wp-content/uploads/2019/12/Systematic-Reviews.jpg https://www.medlior.com/medlior-publications/respiratory/healthcare-resource-utilisation-and-costs-in-patients-experiencing-severe-cardiac-events-following-a-copd-exacerbation-results-from-exacos-cv-studies-in-spain-germany-the-netherlands-and-canada/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/the-risk-of-exacerbation-with-elevated-biomarkers-and-real-world-biomarker-variability-in-patients-with-severe-asthma-a-retrospective-population-based-study/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/short-acting-beta-agonist-saba-antibiotics-oral-corticosteroid-ocs-and-risk-of-mortality-and-cardiopulmonary-events-in-patients-with-chronic-obstructive-pulmonary-disease-copd/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/increased-risk-of-severe-cardiovascular-events-following-exacerbations-of-copd-a-multi-database-cohort-study-presented-at-ers-congress-2023/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/regional-variation-of-copd-burden-in-alberta-canada-presented-at-european-respiratory-society-international-congress/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/increased-risk-of-decompensated-heart-failure-acute-coronary-syndrome-arrhythmias-and-ischaemic-stroke-following-exacerbations-of-copd-results-from-a-multi-database-cohort-study/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/a-population-based-study-of-severe-asthma-exacerbations-and-symptom-control-in-alberta-canada/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/associations-between-medication-use-exacerbations-and-healthcare-utilization-in-copd-a-population-based-study/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/respiratory/a-population-based-study-of-the-burden-of-severe-asthma-in-alberta-canada/ 2025-06-28T05:39:57+00:00 https://www.medlior.com/medlior-publications/oncology/network-meta-analysis-of-first-line-therapy-for-advanced-egfr-mutation-positive-non-small-cell-lung-cancer/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/oncology/systematic-review-and-network-meta-analysis-of-first-line-therapy-for-advanced-egfr-positive-non-small-cell-lung-cancer/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/oncology/a-rapid-literature-review-of-real-world-evidence-in-multiple-myeloma-patient-characteristics-and-health-outcomes/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/chronic-obstructive-pulmonary-disease-discontinuation-of-smoking-offset-for-non-economic-loss-benefits/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/rheumatology/treatment-patterns-and-costs-for-anti-tnf-alpha-biologic-therapy-in-patients-with-psoriatic-arthritis/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/use-of-natural-language-processing-to-examine-real-world-clinical-practice-patterns-in-patients-with-dementia-and-alzheimers-disease-in-one-primary-care-practice-in-ontario-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/burden-of-episodic-migraine-chronic-migraine-and-medication-overuse-headache-in-alberta-can-j-neurol-sci-1-11-2023/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/migraine-treatment-and-healthcare-resource-utilization-in-alberta-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/epidemiology-and-economic-burden-of-huntingtons-disease/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/disease-burden-of-huntingtons-disease-in-a-canadian-setting-using-administrative-health-data-2/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/evaluation-of-health-related-quality-of-life-for-individuals-with-huntingtons-disease-and-care-partners-in-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/burden-of-spinal-muscular-atrophy-sma-on-patients-and-caregivers-in-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/epidemiology-healthcare-resource-utilization-and-healthcare-costs-for-spinal-muscular-atrophy-in-alberta-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/disease-and-treatment-burden-of-spinal-muscular-atrophy-on-patients-and-caregivers-in-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/neurology/a-population-based-study-examining-the-epidemiologic-burden-healthcare-resource-utilization-and-costs-of-spinal-muscular-atrophy-in-alberta-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/oncology/multiple-myeloma-treatment-landscape-from-2011-to-2017-in-alberta-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/oncology/identifying-outcomes-in-real-world-multiple-myeloma-informm-insights-in-methodology-for-using-administrative-health-data-in-alberta/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/oncology/early-mortality-following-diagnosis-of-multiple-myeloma-from-2011-to-2016-in-alberta-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/short-acting-beta-agonists-antibiotics-oral-corticosteroids-and-the-associated-burden-of-copd/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/heightened-long-term-cardiovascular-risks-after-exacerbation-of-chronic-obstructive-pulmonary-disease/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/real-world-biomarker-variability-and-effects-of-biologics-on-severe-asthma-in-alberta/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/benefits-of-inhaled-corticosteroids-ics-in-copd-maintenance-combinations-real-world-evidence-using-longitudinal-targeted-maximum-likelihood-estimation/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/respiratory/leveraging-real-world-data-rwd-to-improve-copd-management-and-patient-outcomes-across-canada/ 2025-06-28T05:39:58+00:00 https://www.medlior.com/medlior-publications/cardiovascular/patterns-of-low-density-lipoprotein-cholesterol-management-and-goal-attainment-in-patients-with-atherosclerotic-cardiovascular-disease-aged-65-years-and-older-from-alberta-and-ontario/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/lipid-lowering-therapy-patterns-and-low-density-lipoprotein-cholesterol-management-among-patients-with-acute-myocardial-infarction-in-alberta-canada-2/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/healthcare-resource-utilization-and-associated-costs-among-patients-with-atherosclerotic-cardiovascular-diseases-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/treatment-and-low-density-lipoprotein-cholesterol-management-in-patients-diagnosed-with-clinical-atherosclerotic-cardiovascular-disease-in-alberta/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/low-density-lipoprotein-cholesterol-management-in-patients-with-atherosclerotic-cardiovascular-diseases-and-pre-existing-diabetes-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/atherosclerotic-cardiovascular-diseases-and-low-density-lipoprotein-cholesterol-management-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/endocrinology/basal-insulin-initiation-in-adults-with-type-2-diabetes-mellitus-a-retrospective-cohort-study-using-administrative-health-data-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/endocrinology/real-world-use-of-guideline-directed-cardioprotective-therapy-in-type-2-diabetes-mellitus-with-atherosclerotic-cardiovascular-disease/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/endocrinology/evidence-of-clinical-inertia-from-a-retrospective-cohort-analysis-of-basal-insulin-initiation-in-type-2-diabetes-mellitus-in-a-canadian-cohort-using-administrative-health-data-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/hematology/comparative-effectiveness-and-safety-and-health-related-quality-of-life-of-haemophilia-a-treatments/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/nephrology/prevalence-of-adult-type-2-diabetes-mellitus-and-related-complications-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/nephrology/acute-and-chronic-complication-profiles-among-patients-with-chronic-kidney-disease-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/nephrology/wcn23-0604-acute-and-chronic-complication-profiles-among-patients-identified-with-chronic-kidney-disease-in-alberta-canada/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/neurology/epidemiology-and-treatment-utilization-for-canadian-patients-with-migraine/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/oncology/indirect-analysis-of-first-line-therapy-for-advanced-non-small-cell-lung-cancer-with-activating-mutations-in-the-japanese-population-2/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/oncology/pcn14-updated-network-meta-analysis-of-first-line-egfr-targeted-tyrosine-kinase-inhibitor-treatments-for-locally-advanced-or-metastatic-non-small-cell-lung-cancer-with-egfr-activating-mutations/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/oncology/indirect-analysis-of-first-line-tyrosine-kinase-inhibitors-for-egfr-nsclc-in-japanese-patients/ 2025-06-28T05:39:59+00:00 https://www.medlior.com/medlior-publications/cardiovascular/guideline-ldl-c-threshold-achievement-in-acute-myocardial-infarction-patients/ 2025-06-28T05:40:20+00:00 https://www.medlior.com/medlior-publications/cardiovascular/trends-in-major-adverse-cardiac-events-during-the-covid-19-pandemic-in-alberta-canada/ 2025-06-28T05:40:20+00:00 https://www.medlior.com/medlior-publications/cardiovascular/pandemic-induced-disruptions-in-troponin-and-low-density-lipoprotein-cholesterol-laboratory-test-volumes-across-alberta/ 2025-06-28T05:40:20+00:00 https://www.medlior.com/medlior-publications/cardiovascular/prevalence-of-atherosclerotic-cardiovascular-disease-and-subsequent-major-adverse-cardiovascular-events-in-alberta-canada/ 2025-06-28T05:40:20+00:00 https://www.medlior.com/medlior-publications/methods/toward-standardized-structured-reporting-for-the-management-of-multiple-myeloma-in-alberta/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/methods/methodological-issues-for-measuring-pharmacotherapy-treatment-and-its-calibration-with-patient-outcomes-using-real-world-data/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/methods/difference-in-differences-method-in-comparative-effectiveness-research/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/bone/canadian-real-world-evidence-on-epidemiology-outcomes-and-economics-of-moderate-to-severe-osteoarthritis-2/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/cardiovascular/lipoprotein-a-levels-and-major-adverse-cardiovascular-events-in-alberta-canada-a-retrospective-cohort-study/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/cardiovascular/real-world-risk-of-recurrent-cardiovascular-events-in-atherosclerotic-cardiovascular-disease-patients-with-ldl-c-above-guideline-recommended-threshold/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/cardiovascular/trends-in-major-adverse-cardiac-events-and-healthcare-utilization-during-the-covid-19-pandemic-in-alberta-canada/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/medlior-publications/cad-reviews/reprocessing-of-single-use-medical-devices-a-2015-update/ 2025-06-28T05:40:21+00:00 https://www.medlior.com/insights/artificial-intelligence-natural-language-processing-data-driven-healthcare-decisions/ 2025-07-10T16:50:25+00:00 https://www.medlior.com/wp-content/uploads/2024/04/AI-image100KB-scaled.jpg https://www.medlior.com/medlior-publications/respiratory/healthcare-resource-utilisation-in-patients-with-exacerbations-of-copd-and-associated-cardiovascular-events-the-exacos-cv-study/ 2026-02-11T18:48:29+00:00 https://www.medlior.com/medlior-publications/cardiovascular/characterization-of-lipoprotein-a-testing-in-alberta-canada-a-retrospective-cohort-study/ 2026-02-11T18:56:53+00:00 https://www.medlior.com/insights/reflecting-on-2025-looking-to-2026-experts-discuss-what-counts-as-high-value-rwd-and-how-evidence-generation-is-changing/ 2026-03-04T01:18:40+00:00 https://www.medlior.com/wp-content/uploads/2026/02/reflections-twentyfive-evidencegenerationnew.png https://www.medlior.com/insights/medlior-and-cf-announce-strategic-partnership-to-accelerate-multinational-real-world-evidence-for-global-life-sciences-research/ 2026-03-04T17:27:14+00:00 https://www.medlior.com/wp-content/uploads/2026/03/Canada-House-Group-Photo-1000w.png https://www.medlior.com/wp-content/uploads/2026/03/UK.png https://www.medlior.com/wp-content/uploads/2026/03/UK.png https://www.medlior.com/wp-content/uploads/2026/03/CA.png https://www.medlior.com/medlior-publications/cardiovascular/lipoproteina-levels-and-major-adverse-cardiovascular-events-in-alberta-canada-a-retrospective-cohort-study/ 2026-06-10T13:05:27+00:00 https://www.medlior.com/medlior-publications/autoimmune/physician-insights-on-cidp-care-in-canada-unmet-needs-access-barriers-and-efgartigimod-sc/ 2026-06-10T13:08:35+00:00 https://www.medlior.com/insights/beyond-clinical-endpoints-hta-has-a-measurement-problem/ 2026-06-10T13:36:10+00:00 https://www.medlior.com/wp-content/uploads/2026/06/medlior_gc_maytwentysix_evbpost.png